-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, U+U94b12EsDBV58cQQaEIG32jUhK8eE4qu4XZjjzUjcPvLA+NR+/zt1++TT2DX6H pL5L/2d6FdFajKLUQMQuqQ== /in/edgar/work/0000903423-00-000449/0000903423-00-000449.txt : 20001018 0000903423-00-000449.hdr.sgml : 20001018 ACCESSION NUMBER: 0000903423-00-000449 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20001007 FILED AS OF DATE: 20001017 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BLOCK DRUG CO INC CENTRAL INDEX KEY: 0000012654 STANDARD INDUSTRIAL CLASSIFICATION: [2844 ] IRS NUMBER: 221375645 STATE OF INCORPORATION: NJ FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 3 SEC ACT: SEC FILE NUMBER: 000-06436 FILM NUMBER: 741423 BUSINESS ADDRESS: STREET 1: 257 CORNELISON AVE CITY: JERSEY CITY STATE: NJ ZIP: 07302 BUSINESS PHONE: 2014343000 MAIL ADDRESS: STREET 1: 257 CORNELISON AVENUE CITY: JERSEY CITY STATE: NJ ZIP: 07302 COMPANY DATA: COMPANY CONFORMED NAME: SMITHKLINE BEECHAM PLC CENTRAL INDEX KEY: 0000850695 STANDARD INDUSTRIAL CLASSIFICATION: [2834 ]OWNER IRS NUMBER: 980101920 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 BUSINESS ADDRESS: STREET 1: ONE NEW HORIZONS COURT STREET 2: BRENTFORD MIDDLESEX CITY: TW8 9EP ENGLAND STATE: X0 MAIL ADDRESS: STREET 1: SMITHKLENE BEECHAM STREET 2: ONE FRANKLIN PLAZA CITY: PHILADELPHIA STATE: PA ZIP: 19101 3 1 0001.txt OMB APPROVAL FORM 3 ---------------------------- OMB Number: 3235-0104 Expires: December 31, 2001 Estimated average burden hours per response.......0.5 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 (Print or Type Responses) ________________________________________________________________________________ 1. Name and Address of Reporting Person* SmithKline Beecham plc - -------------------------------------------------------------------------------- (Last) (First) (Middle) New Horizons Court, Brentford - -------------------------------------------------------------------------------- (Street) Middlesex TW8 9EP, England - -------------------------------------------------------------------------------- (City) (State) (Zip) ________________________________________________________________________________ 2. Date of Event Requiring Statement (Month/Day/Year) 10/7/00 ________________________________________________________________________________ 3. IRS Identification Number of Reporting Person, if an Entity (Voluntary) ________________________________________________________________________________ 4. Issuer Name and Ticker or Trading Symbol Block Drug Company, Inc. (BLOCA) ________________________________________________________________________________ 5. Relationship of Reporting Person to Issuer (Check all applicable) [_] Director [X] 10% Owner [_] Officer (give title below) [_] Other (specify below) ________________________________________________________________________________ 6. If Amendment, Date of Original (Month/Day/Year) ________________________________________________________________________________ 7. Individual or Joint/Group Filing (Check applicable line) [_] Form Filed by One Reporting Person [X] Form Filed by More than One Reporting Person ================================================================================ Table I -- Non-Derivative Securities Beneficially Owned ================================================================================ 3. Ownership Form: 2. Amount of Securities Direct (D) or 1. Title of Security Beneficially Owned Indirect (I) 4. Nature of Indirect Beneficial Ownership (Instr. 4) (Instr. 4) (Instr. 5) (Instr. 4) - ------------------------------------------------------------------------------------------------------------------------------------ Class A Common Stock, par value $.10 per share 0 shares(1) Not applicable Not applicable - ------------------------------------------------------------------------------------------------------------------------------------ Class B Common Stock, par value $.10 per share 0 shares(1) Not applicable Not applicable - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ ====================================================================================================================================
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the Form is filed by more than one Reporting Person, see Instruction 5(b)(v). Potential persons who are to respond to the collection of Information contained in this form are not required to respond unless the form displays a currently valid OMB control number. - ------------ (1) See Explanation of Responses. Page 1 of 4 FORM 3 (continued) Table II -- Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) ================================================================================ 5. Owner- 3. Title and Amount of Securities ship Underlying Derivative Security Form of 2. Date Exercisable (Instr. 4) Derivative and Expiration Date --------------------------------- 4. Conver- Security: (Month/Day/Year) Amount sion or Direct 6. Nature of ---------------------- or Exercise (D) or Indirect Date Expira- Number Price of Indirect Beneficial 1. Title of Derivative Exer- tion of Derivative (I) Ownership Security (Instr. 4) cisable Date Title Shares Security (Instr. 5) (Instr. 5) - ------------------------------------------------------------------------------------------------------------------------------------ Not applicable. - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ ====================================================================================================================================
Explanation of Responses: See Attachment B ** Intentional misstatements or omissions of facts constitute Federal Criminal See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. SMITHKLINE BEECHAM PLC /s/ James Ford 10/17/00 - --------------------------------------- ------------------ **Signature of Reporting Person Date By: Name: James Ford Title: Attorney-in-fact SB ACQUISITION CORP. /s/ Donald F. Parman 10/17/00 - --------------------------------------- ------------------ **Signature of Reporting Person Date By: Name: Donald F. Parman Title: Assistant Secretary Page 2 of 4 Attachment A ------------ Additional Reporting Person SB Acquisition Corp., a New Jersey corporation, located at One Franklin Plaza, 200 N. 16th Street, Philadelphia, Pennsylvania 19101, is a wholly-owned subsidiary of SmithKline Beecham plc and joins SmithKline Beecham plc as a filer for purposes of this Form 3. Page 3 of 4 Attachment B ------------ Explanation of Responses SmithKline Beecham plc ("Parent") and its wholly-owned subsidiary, SB Acquisition Corp. ("Subsidiary"), entered into a Voting and Tender Agreement dated October 7, 2000 with certain shareholders of Block Drug Company, Inc. pursuant to which Parent and Subsidiary have beneficial ownership of certain shares of Class A common stock and Class B common stock of Block Drug Company, Inc., but do not have a pecuniary interest in such shares. Page 4 of 4 -----END PRIVACY-ENHANCED MESSAGE-----